Half Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript
Thank you for standing by, and welcome to the AFT Pharmaceuticals Half Year Results Analyst Briefing. (Operator Instructions)
Representing the company today, we have our Managing Director, Dr. Hartley Atkinson, and Malcolm Tubby, our CFO, from AFT Pharmaceuticals. I would now like to hand the conference over to Hartley Atkinson. Please go ahead.
Thank you, Ashley. Thank you, everyone, for joining us today. So maybe just to go through the presentation, if that's okay. So obviously, we have the first page, which is the title page, Page 2. We have the various disclaimers, so please just be aware of those. They're pretty standard. And maybe then to move on to Page 3, which is the financial highlights for H1 FY 2021. So basically, to look at some top line numbers, The number of countries which we're selling Maxigesic in continues to grow. We're up 21% to 34 countries. That's an important matrix as over time, clearly, as we sell it in more countries, then that will
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
